Showing results (2301-2310 of 2,381) with videos related to
Sort By:
Pageof 239
Cancer Research|July 26, 2018
Phase Ib Results of the Rational Combination of Selumetinib and Cyclosporin A in Advanced Solid Tumors with an Expansion Cohort in Metastatic Colorectal CancerAnuradha Krishnamurthy, Arvind Dasari, Anne M Noonan, et al.Handchirurgie, Mikrochirurgie, Plastische Chirurgie : Organ Der Deutschsprachigen Arbeitsgemeinschaft Fur Handchirurgie : Organ Der Deutschsprachigen Arbeitsgemeinschaft Fur Mikrochirurgie Der Peripheren Nerven Und Gefasse : Organ Der V|August 12, 2025
[Do We Need an Amputee Outpatient Clinic? How Innovations Promote Interdisciplinarity in Amputation Medicine]Dominik Behringer, Magnus Kalff, Nora Kirsten, et al.Annals of Clinical and Translational Neurology|August 7, 2023
Automated detection of immune effector cell-associated neurotoxicity syndrome via quantitative EEGChristine A Eckhardt, Haoqi Sun, Preeti Malik, et al.Journal of Proteome Research|March 3, 2025
Affinity Purification Mass Spectrometry on the Orbitrap-Astral Mass Spectrometer Enables High-Throughput Protein-Protein Interaction MappingLia R Serrano, Adrian Pelin, Tabiwang N Arrey, et al.Disease Models & Mechanisms|January 31, 2015
Functional and molecular characterisation of EO771.LMB tumours, a new C57BL/6-mouse-derived model of spontaneously metastatic mammary cancerCameron N Johnstone, Yvonne E Smith, Yuan Cao, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2011
Documenting the natural history of patients with resected stage II adenocarcinoma of the colon after random assignment to adjuvant treatment with edrecolomab or observation: results from CALGB 9581Donna Niedzwiecki, Monica M Bertagnolli, Robert S Warren, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2013
Multicenter phase I trial of the mitogen-activated protein kinase 1/2 inhibitor BAY 86-9766 in patients with advanced cancerColin D Weekes, Daniel D Von Hoff, Alex A Adjei, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2013
Rational combination of a MEK inhibitor, selumetinib, and the Wnt/calcium pathway modulator, cyclosporin A, in preclinical models of colorectal cancerAnna Spreafico, John J Tentler, Todd M Pitts, et al.Molecular Cancer Therapeutics|December 30, 2021
Preclinical Development of the Class-I-Selective Histone Deacetylase Inhibitor OKI-179 for the Treatment of Solid TumorsJennifer R Diamond, Todd M Pitts, Dana Ungermannova, et al.Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society|July 2, 2025
Inter-Rater Reliability of EEG-Based Encephalopathy GradingRyan A Tesh, Anika Zahoor, Jayme Banks, et al.Pageof 239